Showing results (21-30 of 77) with videos related to
Sort By:
Pageof 8
The Journal of Antimicrobial Chemotherapy|August 1, 2023
Antibacterial effect of seven days exposure to ceftolozane-tazobactam as monotherapy and in combination with fosfomycin or tobramycin against Pseudomonas aeruginosa with ceftolozane-tazobactam MICs at or above 4 mg/l in an in vitro pharmacokinetic modelMarie Attwood, Pippa Griffin, Alan R Noel, et al.BMC Medical Research Methodology|October 1, 2021
Analytical challenges in estimating the effect of exposures that are bounded by follow-up time: experiences from the Blood Stream Infection-Focus on Outcomes studyRebecca Evans, Katie Pike, Alasdair MacGowan, et al.Antimicrobial Agents and Chemotherapy|December 30, 2015
Suppression of Emergence of Resistance in Pathogenic Bacteria: Keeping Our Powder Dry, Part 1G L Drusano, Arnold Louie, Alasdair MacGowan, et al.The Journal of Antimicrobial Chemotherapy|February 9, 2022
Comparative bactericidal activity of representative β-lactams against Enterobacterales, Acinetobacter baumannii and Pseudomonas aeruginosaAlan R Noel, Marie Attwood, Karen E Bowker, et al.Plos One|May 20, 2022
Emulating the MERINO randomised control trial using data from an observational cohort and trial of rapid diagnostic (BSI-FOO)Rebecca N Evans, Jessica Harris, Chris A Rogers, et al.BMJ Open|May 4, 2019
Challenges and opportunities for involving patients and the public in acute antimicrobial medicine development research: an interview studyAndy Gibson, Michele Kok, David Evans, et al.Neurourology and Urodynamics|May 16, 2017
The use of intravesical gentamicin to treat recurrent urinary tract infections in lower urinary tract dysfunctionPaul Abrams, Hashim Hashim, Charles Tomson, et al.Journal of Clinical Pathology|March 6, 2007
Problems of basing patient recruitment for primary care studies on routine laboratory submissionsCliodna McNulty, Michael Thomas, Rhiannon John, et al.BMJ Open|October 19, 2021
Cost-effectiveness of rapid laboratory-based mass-spectrometry diagnosis of bloodstream infection: evidence from the RAPIDO randomised controlled trialPadraig Dixon, William Hollingworth, Katie Pike, et al.The Journal of Antimicrobial Chemotherapy|May 7, 2004
Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001-2002: the BSAC Bacteraemia Resistance Surveillance ProgrammeRosy Reynolds, Nicola Potz, Melissa Colman, et al.Pageof 8